期刊列表 » 期刊详情

1、该刊只有国际刊号！

2、投稿方式：在线投稿。

3、官网网址：

https://onlinelibrary.wiley.com/journal/13652184

4、投稿系统：

https://wiley.atyponrex.com/journal/CPR

5、官网邮箱：CPReditorialoffice@wiley.com

6、出刊日期：月刊，一年出版12期。

2026年1月29日星期四

Author Guidelines

【官网信息】

1. Submission and Peer Review Process

Thank

you for your interest in Cell Proliferation. Please note that

submission implies that the content has not been published or submitted

for publication elsewhere except as a brief abstract in the proceedings

of a scientific meeting on symposium.

New

submissions should be made via the Research Exchange submission portal

https://wiley.atyponrex.com/journal/CPR. You may check the status of

your submission at any time by logging on to submission.wiley.com and

clicking the "My Submissions" button. For technical help with the

submission system, please review our FAQs or contact

submissionhelp@wiley.com.

For help with submissions, please contact: CPReditorialoffice@wiley.com

1.1 Article Preparation Support

Wiley

Editing Services offers expert help with English Language Editing, as

well as translation, manuscript formatting, figure illustration, figure

formatting, and graphical abstract design – so you can submit your

manuscript with confidence.

Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.

1.2 Free Format Submission

Cell Proliferation offers Free Format submission for a simplified and streamlined submission process.

Before you submit, you will need:

Your

manuscript: this should be an editable file including text, figures,

and tables, or separate files—whichever you prefer. All required

sections should be contained in your manuscript, including abstract,

introduction, methods, results, and conclusions (For details, see

Section 2). Figures and tables should have legends. Figures should be

uploaded in the highest resolution possible (For details, see Section

1.11). If the figures are not of sufficiently high quality, your

manuscript may be delayed. References may be submitted in any style or

format, as long as it is consistent throughout the manuscript.

Supporting information should be submitted in separate files. If the

manuscript, figures or tables are difficult for you to read, they will

also be difficult for the editors and reviewers, and the editorial

office will send it back to you for revision. Your manuscript may also

be sent back to you for revision if the quality of English language is

poor.

1.3 Open Access

This

journal is a Gold Open Access journal. Submissions will be subject to

an APC if accepted and published in the journal. You can read more about

APCs and whether you may be eligible for waivers or discounts, through

your institution, funder, or a country waiver. For more information on

this journal’s APCs and licensing policy, please visit the journal’s

Open Access page.

1.4 Preprint Policy

Please find the Wiley preprint policy here.

This journal accepts articles previously published on preprint servers.

Cell

Proliferation will consider for review articles previously available as

preprints. You are requested to update any pre-publication versions

with a link to the final published article. You may also post the final

published version of the article immediately after publication.

1.5 Data Policies

When

you submit a manuscript to this journal, it is imperative to follow the

guidelines regarding data sharing, citation, and protection as outlined

below:

Data Sharing and Availability

This

journal expects and peer reviews data sharing. Review Wiley’s Data

Sharing Policy where you will be able to see and select the data

availability statement that is right for your submission.

Data Citation

Please review Wiley’s Data Citation Policy.

Data Protection

By

submitting a manuscript to or reviewing for this publication, your

name, email address, and affiliation, and other contact details the

publication might require, will be used for the regular operations of

the publication. Please review Wiley’s Data Protection Policy to learn

more.

1.6 Funding

You

should list all funding sources in the Acknowledgments section. You are

responsible for the accuracy of their funder designation. If in doubt,

please check the Open Funder Registry for the correct nomenclature.

1.7 Authorship, Pronouns, and ORCID

Authorship

All

listed authors should have contributed to the manuscript substantially

and have agreed to the final submitted version. Review editorial

standards and scroll down for a description of authorship criteria.

Author Pronouns

Authors

may now include their personal pronouns in the author bylines of their

published articles and on Wiley Online Library. Authors will never be

required to include their pronouns; it will always be optional for the

author. Authors can include their pronouns in their manuscript upon

submission and can add, edit, or remove their pronouns at any stage upon

request. Submitting/corresponding authors should never add, edit, or

remove a coauthor’s pronouns without that coauthor’s consent. Where

post-publication changes to pronouns are required, these can be made

without a correction notice to the paper, following Wiley’s Name Change

Policy to protect the author’s privacy. Terms which fall outside of the

scope of personal pronouns (e.g. proper or improper nouns), are

currently not supported.

ORCID

An

ORCID ID, freely available at https://orcid.org. (Why is this

important? Your article, if accepted and published, will be attached to

your ORCID profile. Institutions and funders are increasingly requiring

authors to have ORCID IDs.)

This

journal requires the submitting author (only) to provide an ORCID iD

when submitting a manuscript. This takes around 2 minutes to complete.

Please refer to Wiley’s resources on ORCID.

1.8 Reproduction of Copyright Material

If

excerpts from copyrighted works owned by third parties are included,

all sources must be credited within the manuscript. At minimum, the

title and author should be provided.

The

corresponding author is responsible for obtaining written permission to

reproduce the material "in print and other media" from the publisher of

the original source, and for supplying Wiley with that permission upon

request

For more information, review Wiley’s Guidelines for Obtaining Permission to Reproduce Material.

1.9 Title Page

The

title page of the manuscript, including: Your co-author details,

affiliation, email address, and so on. (Why is this important? We need

to keep all co-authors informed of the outcome of the peer review

process.)

Title: A brief informative title containing the major key words. The title should not contain abbreviations.

Authors: The full names of the authors Please provide institutional email address for corresponding author(s)

Affiliations:

The author's institutional affiliations where the work was conducted,

with a footnote for the author’s present address if different from where

the work was conducted, for example: “1 [Department/Institute],

[University], [City] [Postal code], [Country]”.

A short running title of less than 40 characters (optional);

1.10 Main Text

Abstract: Abstract structured (introduction/methods/results/conclusion) or unstructured, less than 300 words;

Keywords: Up to seven keywords;

Key

points (optional): Practitioner Points (optional) Authors will need to

provide no more than 3 ‘key points’, written with the practitioner in

mind, that summarize the key messages of their paper to be published

with their article;

Main

body: formatted as introduction, materials & methods (optional),

results, discussion, conclusion. Throughout the paper, please check the

usage of Latin, species, protein and gene symbols, abbreviations, and

names. Content in Latin should be in italics. For species names in

Latin, please use the full Latin name at the first mention and then use

the abbreviation afterward. Protein abbreviations/symbols are normally

in Roman font (upright type), while the gene symbols/names should be in

italics, normally in upper case for human genes (e.g., CMH1 and HPR) and

in lower case with an initial capital for animal genes (viz. mouse;

e.g., Hras1 and Tcra);

Statements:

Statements relating to our ethics and integrity policies, which may

include any of the following (Why are these important? We need to uphold

rigorous ethical standards for the research we consider for

publication):

Author

contributions: This journal encourages the CRediT (Contribution Roles

Taxonomy)—more information is available on our Author Services This

section is a required section to indicate contribution from each author;

Data availability statement: see Section 1.5 for details;

Acknowledgments:

Please acknowledge the funding agencies if available, provide the full

name (including country name) of the program and grant No. if possible.

Please also acknowledge people who help with the study or manuscript

preparation;

Conflict

of interest: Cell Proliferationrequires that all authors disclose any

potential sources of conflict of interest. Any interest or relationship,

financial or otherwise that might be perceived as influencing an

author's objectivity is considered a potential source of conflict of

interest. These must be disclosed when directly relevant or directly

related to the work that the authors describe in their manuscript.

Potential sources of conflict of interest include, but are not limited

to, patent or stock ownership, membership of a company board of

directors, membership of an advisory board or committee for a company,

and consultancy for or receipt of speaker's fees from a company. The

existence of a conflict of interest does not preclude publication. If

the authors have no conflict of interest to declare, they must also

state this at submission. It is the responsibility of the corresponding

author to review this policy with all authors and collectively to

disclose with the submission ALL pertinent commercial and other

relationships. The Conflict of Interest statement should be included

within the main text file of your submission;

Ethics

approval statement: This journal requires that you include in the

manuscript details IRB approvals, ethical treatment of human and animal

research participants, and gathering of informed consent, as

appropriate. You will be expected to declare all conflicts of interest,

or none, on submission. Please review Wiley’s policies surrounding human

studies, animal studies, clinical trial registration, biosecurity, and

research reporting guidelines;

This

journal follows the core practices of the Committee on Publication

Ethics (COPE) and handles cases of research and publication misconduct

accordingly (https://publicationethics.org/core-practices);

This

journal uses iThenticate’s CrossCheck software to detect instances of

overlapping and similar text in submitted manuscripts. Read Wiley’s Top

10 Publishing Ethics Tips for Authors and Wiley’s Publication Ethics

Guidelines;

Patient consent statement;

Permission to reproduce material from other sources;

Clinical trial registration.

References:

This journal uses AMA reference style. Review your reference style

guidelines prior to submission. As this journal offers Free Format

submission, however, this is for information only and you do not need to

format the references in your article. This will instead be taken care

of by the typesetter;

Tables:

Tables should be self-contained and complement, not duplicate,

information contained in the text. They should be supplied as editable

files, not pasted as images. Legends should be concise but comprehensive

– the table, legend, and footnotes must be understandable without

reference to the text. All abbreviations must be defined in footnotes.

Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **,

*** should be reserved for P-values. Statistical measures such as SD or

SEM should be identified in the headings;

Figures:

Please review the Guidelines for the preparation of figuresfor

manuscripts for peer review, as well as the more detailed

post-acceptance figure requirements. If the figures are not of

sufficiently high quality your manuscript may be delayed. Legends should

be concise but comprehensive – the figure and its legend must be

understandable without reference to the text. Include definitions of any

symbols used and define/explain all abbreviations and units of

measurement.

1.11 Figures and Supporting Information

Figures,

supporting information, and appendices should be supplied as separate

files. You should review the basic figure requirements for manuscripts

for peer review, as well as the more detailed post-acceptance figure

requirements. View Wiley’s FAQs on supporting information.

1.12 Graphical TOC/Abstract

Graphical

Abstract is mandatory for original article or review article, while

optional for other article types. It is a single, concise visual summary

of the main topics and if possible key findings of the article to draw

the reader to the whole paper. In our submission system, you are

required to submit the following items separately:

(1)

A short statement of 50 words or less (1-2 sentences) to be published

in the Table of Contents that describes the key findings and main

message of the work. This caption will appear alongside the Graphical

Abstract Image that you provide as a separate file.

(2)

An illustration to be published in the Table of Contents to assist

non-specialists in understanding the context and significance of your

research. The image supplied should fit within the dimensions of 50 mm x

60 mm and be fully legible at this size. This image will be captioned

with the Graphical Abstract Text that you supply as a separate file;

Graphical

Abstracts can be shared and reproduced via all social media without

limitation, for the benefit of spreading important research information.

Authors

are responsible for obtaining permission to use any images that they

include from outside sources, including articles, web pages, stock photo

sites or Google image searches. Any needed permissions must be

submitted along with your graphical abstract or identified in the

Acknowledgements section of your manuscript.

1.13 LaTeX Guidelines for Submission

For

authors requiring a LaTeX template, we strongly recommend reviewing

Wiley’s New Journal Design (NJD) LaTeX Authoring Template.

LaTeX Guidelines for Post-Acceptance:

Please check that you have supplied the following files for typesetting post-acceptance:

PDF of the finalized source manuscript files compiled without any errors.

The

LaTeX source code files (text, figure captions, and tables, preferably

in a single file), BibTeX files (if used), any associated packages/files

along with all other files needed for compiling without any errors.

This is particularly important if authors have used any LaTeX style or

class files, bibliography files (.bbl, .bst. .blg) or packages apart

from those used in the NJD LaTeX Template class file.

Electronic

graphics files for the illustrations in Encapsulated PostScript (EPS),

PDF or TIFF format. Authors are requested not to create figures using

LaTeX codes.

1.14 Peer Review

This

journal operates a single-anonymized peer review policy. Except where

otherwise stated, manuscripts are peer reviewed by at least two

anonymous reviewers and an Associate or Assistant Editor. Papers will

only be sent to review if the Editor-in-Chief determines that the paper

meets the appropriate quality and relevance requirements.

In-house

submissions, i.e. papers authored by Editors or Editorial Board members

of the title, will be sent to Editors unaffiliated with the author or

institution and monitored carefully to ensure there is no peer review

bias.

Wiley's policy on the confidentiality of the review process is available here.

1.15 Refer and Transfer Program

Wiley

believes that no valuable research should go unshared. This journal

participates in Wiley’s Refer & Transfer program. If your manuscript

is not accepted, you may receive a recommendation to transfer your

manuscript to another suitable Wiley journal, either through a referral

from the journal’s editor or through our Transfer Desk Assistant.

1.16 Appeals and Complaints

Authors

may appeal an editorial decision if they feel that the decision to

reject was based on either a significant misunderstanding of a core

aspect of the manuscript, a failure to understand how the manuscript

advances the literature or concerns regarding the manuscript-handling

process. Differences in opinion regarding the novelty or significance of

the reported findings are not considered as grounds for appeal. To

raise an appeal, please contact this journal by email, quoting your

manuscript ID number and explaining your rationale for the appeal. The

editor’s decision following an appeal consideration is final.

To

raise a complaint regarding editorial staff, policy or process please

contact the journal in the first instance. If you believe further

support outside the journal’s management is necessary, please refer to

Wiley’s Best Practice Guidelines on Research Integrity and Publishing

Ethics.

1.17 AI Policy

Artificial

Intelligence Generated Content (AIGC) tools—such as ChatGPT and others

based on large language models (LLMs)—cannot be considered capable of

initiating an original piece of research without direction by human

authors. They also cannot be accountable for a published work or for

research design, which is a generally held requirement of authorship (as

discussed in the previous section), nor do they have legal standing or

the ability to hold or assign copyright. Therefore—in accordance with

COPE’s position statement on AI tools—these tools cannot fulfill the

role of, nor be listed as, an author of an article. If an author has

used this kind of tool to develop any portion of a manuscript, its use

must be described, transparently and in detail, in the Methods or

Acknowledgements section. The author is fully responsible for the

accuracy of any information provided by the tool and for correctly

referencing any supporting work on which that information depends. Tools

that are used to improve spelling, grammar, and general editing are not

included in the scope of these guidelines. The final decision about

whether use of an AIGC tool is appropriate or permissible in the

circumstances of a submitted manuscript or a published article lies with

the journal’s editor or other party responsible for the publication’s

editorial policy.

......

更多详见：

https://onlinelibrary.wiley.com/page/journal/13652184/homepage/forauthors.html